In the courts, in the Administration, and in drug maker initiatives, action on the Section 340B prescription drug discount program has not cooled down this winter. The program has been the subject of an executive order, multiple lawsuits, potential legislation, and actions by pharmaceutical manufacturers to address perceived compliance issues in the 340B contract pharmacy context. This webinar will provide details on these issues (including a 60-day freeze of President Trump’s executive order regarding federally qualified health center prices for insulin and injectable epinephrine), insights into the political backdrop that is influencing these actions, and information about how health centers can effectively advocate to continue this important program for our patients.
Sue Veer, MBA, CMPE
President and CEO, Carolina Health Centers, Inc.
Please note: You will need to register for each call individually. Please do not forward your confirmation email or the Zoom meeting link to others as TACHC needs to gather attendance information for grant purposes.
You can contact Cecile Carson for content information and TaSheena Mitchell for registration assistance.